Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0428
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes ; volume:60 ; number:6 ; day:6 ; month:4 ; year:2017 ; pages:989-997 ; date:6.2017
Diabetologia ; 60, Heft 6 (6.4.2017), 989-997, 6.2017
- Creator
-
Berk, Kirsten A.
- Contributor
-
Yahya, Reyhana
Verhoeven, Adrie J. M.
Touw, Jeanette
Leijten, Frank P.
Rossum, Elisabeth F. van
Wester, Vincent L.
Lips, Mirjam A.
Pijl, Hanno
Timman, Reinier
Erhart, Gertraud
Kronenberg, Florian
Roeters van Lennep, Jeanine E.
Sijbrands, Eric J. G.
Mulder, Monique T.
SpringerLink (Online service)
- DOI
-
10.1007/s00125-017-4246-y
- URN
-
urn:nbn:de:101:1-2018080909515904481634
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Berk, Kirsten A.
- Yahya, Reyhana
- Verhoeven, Adrie J. M.
- Touw, Jeanette
- Leijten, Frank P.
- Rossum, Elisabeth F. van
- Wester, Vincent L.
- Lips, Mirjam A.
- Pijl, Hanno
- Timman, Reinier
- Erhart, Gertraud
- Kronenberg, Florian
- Roeters van Lennep, Jeanine E.
- Sijbrands, Eric J. G.
- Mulder, Monique T.
- SpringerLink (Online service)
Other Objects (12)
Lipoprotein(a): from Causality to Treatment
Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases
Prediction of cardiovascular risk by Lp(a) concentrations or genetic variants within the LPA gene region
Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus
Lipoprotein(a)
Frequent LPA KIV-2 variants lower lipoprotein(a) concentrations and protect against coronary artery disease
Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature
Genomweite Assoziationsstudien zu Adipositas und was wir daraus lernen
An optimized procedure for the design and evaluation of Ecotilling assays
The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A
Lipoprotein(a) in nephrological patients
Supporting the evidence for human trait-associated genetic variants by computational biology methods and multi-level data integration.
Lipoprotein(a): from Causality to Treatment
Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases
Prediction of cardiovascular risk by Lp(a) concentrations or genetic variants within the LPA gene region
Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus
Lipoprotein(a)
Frequent LPA KIV-2 variants lower lipoprotein(a) concentrations and protect against coronary artery disease
Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature
Genomweite Assoziationsstudien zu Adipositas und was wir daraus lernen
An optimized procedure for the design and evaluation of Ecotilling assays
The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A
Lipoprotein(a) in nephrological patients
Supporting the evidence for human trait-associated genetic variants by computational biology methods and multi-level data integration.
Lipoprotein(a): from Causality to Treatment
Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases
Prediction of cardiovascular risk by Lp(a) concentrations or genetic variants within the LPA gene region
Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus
Lipoprotein(a)
Frequent LPA KIV-2 variants lower lipoprotein(a) concentrations and protect against coronary artery disease
Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature
Genomweite Assoziationsstudien zu Adipositas und was wir daraus lernen
An optimized procedure for the design and evaluation of Ecotilling assays
The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A
Lipoprotein(a) in nephrological patients